Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    23764539 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
To Top

† Indicates status has not been verified in more than two years